Company Filing History:
Years Active: 2011-2012
Title: Andrei Korostylev: Innovator in Pharmaceutical Chemistry
Introduction
Andrei Korostylev is a notable inventor based in Ryazan, Russia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for producing important medicinal compounds. With a total of 2 patents to his name, Korostylev's work has the potential to impact the treatment of various health conditions.
Latest Patents
Korostylev's latest patents include a method for the production of statins and a process for preparing pyrrole derivatives and intermediates. The first patent relates to a process for producing statins, which are known as HMG-CoA reductase inhibitors. This invention not only outlines the production process but also introduces novel intermediate compounds that are essential for the synthesis of these important drugs. The second patent focuses on preparing pyrrole derivatives that effectively inhibit cholesterol biosynthesis in humans. This invention details improved synthetic methods for creating 3,5-dihydroxy-7-pyrrol-1-yl heptanoic acids from 1,4-diketo starting materials, along with the intermediates involved in this process.
Career Highlights
Andrei Korostylev is currently associated with Ratiopharm GmbH, a company known for its commitment to developing high-quality pharmaceuticals. His work at Ratiopharm has allowed him to further his research and contribute to innovative solutions in the pharmaceutical industry.
Collaborations
Throughout his career, Korostylev has collaborated with esteemed colleagues such as Armin Boerner and Vitali Tararov. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.
Conclusion
Andrei Korostylev's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and showcases the importance of innovation in the pharmaceutical industry.